| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.39▲ | 3.42▼ | 3.43▼ | 3.41▼ | 3.48▼ |
| MA10 | 3.41▼ | 3.43▼ | 3.41▼ | 3.42▼ | 3.54▼ |
| MA20 | 3.42▼ | 3.41▼ | 3.37▲ | 3.47▼ | 3.66▼ |
| MA50 | 3.43▼ | 3.39▲ | 3.40▲ | 3.59▼ | 2.88▲ |
| MA100 | 3.42▼ | 3.41▼ | 3.44▼ | 3.61▼ | 2.67▲ |
| MA200 | 3.37▲ | 3.44▼ | 3.44▼ | 2.90▲ | 3.86▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.002▼ | 0.007▲ | 0.000▼ | -0.087▼ |
| RSI | 43.155▼ | 49.936▼ | 50.796▲ | 47.294▼ | 51.305▲ |
| STOCH | 12.857▼ | 26.042 | 58.824 | 44.852 | 34.386 |
| WILL %R | -68.750 | -67.647 | -57.500 | -52.885 | -67.857 |
| CCI | -57.037 | -106.576▼ | -9.987 | -15.939 | -67.693 |
|
Tuesday, September 15, 2026 12:11 PM
Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment.FDA has revised the Generic Drugs User Fee Act (GDUFA) Goal Date to ...
|
|
Monday, September 14, 2026 08:26 AM
KETAFREE can turn NRx Pharmaceuticals’ ketamine opportunity into a commercial business, provided FDA approval leads to a successful launch. More on NRXP stock.
|
|
Monday, September 14, 2026 04:19 AM
GeNeuro, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), announced it has been awarded a European patent (EP 3 570 878 B1) for GNK-301, a monoclonal antibody drug candidate targeting ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/26 | 3.39 | 3.52 | 3.37 | 3.405 | 763,565 |
| 16/09/26 | 3.39 | 3.45 | 3.32 | 3.35 | 716,043 |
| 15/09/26 | 3.46 | 3.47 | 3.16 | 3.40 | 1,257,746 |
| 14/09/26 | 3.37 | 3.605 | 3.35 | 3.49 | 1,205,425 |
| 11/09/26 | 3.44 | 3.44 | 3.37 | 3.40 | 356,231 |
| 10/09/26 | 3.36 | 3.45 | 3.32 | 3.40 | 480,116 |
| 09/09/26 | 3.48 | 3.52 | 3.34 | 3.37 | 520,713 |
| 08/09/26 | 3.50 | 3.54 | 3.42 | 3.47 | 705,974 |
| 04/09/26 | 3.43 | 3.50 | 3.39 | 3.49 | 487,720 |
| 03/09/26 | 3.48 | 3.50 | 3.425 | 3.43 | 237,362 |
|
|
||||
|
|
||||
|
|